These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 15809411

  • 1. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG.
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of a three-tier formulary on antidepressant utilization and expenditures.
    Hodgkin D, Parks Thomas C, Simoni-Wastila L, Ritter GA, Lee S.
    J Ment Health Policy Econ; 2008 Jun; 11(2):67-77. PubMed ID: 18509214
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs.
    Fairman KA, Motheral BR, Henderson RR.
    Clin Ther; 2003 Dec; 25(12):3147-61; discussion 3144-6. PubMed ID: 14749153
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
    Klepser DG, Huether JR, Handke LJ, Williams CE.
    J Manag Care Pharm; 2007 Dec; 13(9):765-77. PubMed ID: 18062728
    [Abstract] [Full Text] [Related]

  • 8. The effect of three-tier formulary adoption on medication continuation and spending among elderly retirees.
    Huskamp HA, Deverka PA, Landrum MB, Epstein RS, McGuigan KA.
    Health Serv Res; 2007 Oct; 42(5):1926-42. PubMed ID: 17850526
    [Abstract] [Full Text] [Related]

  • 9. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.
    Motheral B, Fairman KA.
    Med Care; 2001 Dec; 39(12):1293-304. PubMed ID: 11717571
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incentive formularies and changes in prescription drug spending.
    Landon BE, Rosenthal MB, Normand SL, Spettell C, Lessler A, Underwood HR, Newhouse JP.
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW, Brook RH, Keeler E, Mangione CM.
    JAMA; 2003 Jul 09; 290(2):222-7. PubMed ID: 12851277
    [Abstract] [Full Text] [Related]

  • 14. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB, Huskamp HA, Winn AN, Basch E, Keating NL.
    JAMA Oncol; 2018 Jun 14; 4(6):e173598. PubMed ID: 29121177
    [Abstract] [Full Text] [Related]

  • 15. Are incentive-based formularies inversely associated with drug utilization in managed care?
    Gleason PP, Gunderson BW, Gericke KR.
    Ann Pharmacother; 2005 Feb 14; 39(2):339-45. PubMed ID: 15644478
    [Abstract] [Full Text] [Related]

  • 16. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT, Barnes J, Shea T, Coulter SL.
    J Manag Care Pharm; 2006 Oct 14; 12(8):665-76. PubMed ID: 17269845
    [Abstract] [Full Text] [Related]

  • 17. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.
    Yeung K, Basu A, Hansen RN, Watkins JB, Sullivan SD.
    Med Care; 2017 Feb 14; 55(2):191-198. PubMed ID: 27579915
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Managing prescription drug costs.
    Sica JM.
    Empl Benefits J; 2001 Mar 14; 26(1):35-40. PubMed ID: 11272515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.